|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
130 a.a.
|
 |
|
|
|
|
|
|
|
204 a.a.
|
 |
|
|
|
|
|
|
|
195 a.a.
|
 |
|
|
|
|
|
|
|
131 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system/cytokine
|
 |
|
Title:
|
 |
Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2
|
|
Structure:
|
 |
Interleukin-2 receptor alpha chain. Chain: a, e. Synonym: il-2 receptor alpha subunit, il-2-ra, il2-ra, p55, cd25, tac antigen. Engineered: yes. Mutation: yes. Interleukin-2 receptor beta chain. Chain: b, f. Synonym: il-2 receptor beta subunit, il-2-rb, p75, cd122.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: il2ra. Expressed in: trichoplusia ni. Expression_system_taxid: 7111. Gene: il2rb. Gene: il2rg. Gene: il2.
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.223
|
R-free:
|
0.263
|
|
|
Authors:
|
 |
E.W.Debler,D.J.Stauber,I.A.Wilson
|
Key ref:
|
 |
D.J.Stauber
et al.
(2006).
Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor.
Proc Natl Acad Sci U S A,
103,
2788-2793.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
25-Oct-05
|
Release date:
|
21-Feb-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P01589
(IL2RA_HUMAN) -
Interleukin-2 receptor subunit alpha from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
272 a.a.
130 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P14784
(IL2RB_HUMAN) -
Interleukin-2 receptor subunit beta from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
551 a.a.
204 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
103:2788-2793
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor.
|
|
D.J.Stauber,
E.W.Debler,
P.A.Horton,
K.A.Smith,
I.A.Wilson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
IL-2 is a cytokine that functions as a growth factor and central regulator in
the immune system and mediates its effects through ligand-induced
hetero-trimerization of the receptor subunits IL-2R alpha, IL-2R beta, and
gamma(c). Here, we describe the crystal structure of the trimeric assembly of
the human IL-2 receptor ectodomains in complex with IL-2 at 3.0 A resolution.
The quaternary structure is consistent with a stepwise assembly from IL-2/IL-2R
alpha to IL-2/IL-2R alpha/IL-2R beta to IL-2/IL-2R alpha/IL-2R beta/gamma(c).
The IL-2R alpha subunit forms the largest of the three IL-2/IL-2R interfaces,
which, together with the high abundance of charge-charge interactions,
correlates well with the rapid association rate and high-affinity interaction of
IL-2R alpha with IL-2 at the cell surface. Surprisingly, IL-2R alpha makes no
contacts with IL-2R beta or gamma(c), and only minor changes are observed in the
IL-2 structure in response to receptor binding. These findings support the
principal role of IL-2R alpha to deliver IL-2 to the signaling complex and act
as regulator of signal transduction. Cooperativity in assembly of the final
quaternary complex is easily explained by the extraordinarily extensive set of
interfaces found within the fully assembled IL-2 signaling complex, which nearly
span the entire length of the IL-2R beta and gamma(c) subunits. Helix A of IL-2
wedges tightly between IL-2R beta and gamma(c) to form a three-way junction that
coalesces into a composite binding site for the final gamma(c) recruitment. The
IL-2/gamma(c) interface itself exhibits the smallest buried surface and the
fewest hydrogen bonds in the complex, which is consistent with its promiscuous
use in other cytokine receptor complexes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Interface between IL-2R and IL-2. Open-book
representation of the IL-2/IL-2R interface. The
electrostatic potential was mapped onto the molecular surface
and contoured at ±35kT/eV (blue/red). The interface
features a hydrophobic center, flanked by a large number of salt
bridges and other polar contacts. The strong electrostatic
component of this interaction serves to rapidly capture IL-2
and, thus, to dominate the k[on] rate of IL-2 binding to the
IL-2R.
|
 |
Figure 5.
Fig. 5. Three-way junction between IL-2, IL-2R , and
[c]. IL-2 (yellow
ribbon representation), IL-2R , and [c] (the
surfaces are colored as in Figs. 3 and 4) form a three-way
junction at the heart of the high-affinity IL-2 signaling
complex. The network of residues that mediate these contacts
(colored red) provides a compelling structural basis for
cooperativity in the IL-2/IL-2R complex assembly.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Yang,
J.Wang,
J.Du,
C.Zhong,
D.Zhang,
H.Guo,
Y.Guo,
and
J.Ding
(2010).
Structural basis of immunosuppression by the therapeutic antibody daclizumab.
|
| |
Cell Res,
20,
1361-1371.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.W.Stonier,
and
K.S.Schluns
(2010).
Trans-presentation: a novel mechanism regulating IL-15 delivery and responses.
|
| |
Immunol Lett,
127,
85-92.
|
 |
|
|
|
|
 |
C.L.McClendon,
G.Friedland,
D.L.Mobley,
H.Amirkhani,
and
M.P.Jacobson
(2009).
Quantifying Correlations Between Allosteric Sites in Thermodynamic Ensembles.
|
| |
J Chem Theory Comput,
5,
2486-2502.
|
 |
|
|
|
|
 |
D.Gómez-Martín,
M.Díaz-Zamudio,
J.C.Crispín,
and
J.Alcocer-Varela
(2009).
Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities.
|
| |
Autoimmun Rev,
9,
34-39.
|
 |
|
|
|
|
 |
D.V.Liu,
L.M.Maier,
D.A.Hafler,
and
K.D.Wittrup
(2009).
Engineered interleukin-2 antagonists for the inhibition of regulatory T cells.
|
| |
J Immunother,
32,
887-894.
|
 |
|
|
|
|
 |
J.Wang,
L.S.Wicker,
and
P.Santamaria
(2009).
IL-2 and its high-affinity receptor: genetic control of immunoregulation and autoimmunity.
|
| |
Semin Immunol,
21,
363-371.
|
 |
|
|
|
|
 |
M.H.Pham,
N.Kondapalli,
C.L.Reckord,
and
P.D.Foglesong
(2009).
Interleukin-2 induces the activities of DNA topoisomerase I and DNA topoisomerase II in HuT 78 cells.
|
| |
Biochem Biophys Res Commun,
390,
577-580.
|
 |
|
|
|
|
 |
R.Dey,
K.Ji,
Z.Liu,
and
L.Chen
(2009).
A cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex.
|
| |
PLoS ONE,
4,
e5188.
|
 |
|
|
|
|
 |
T.R.Hercus,
D.Thomas,
M.A.Guthridge,
P.G.Ekert,
J.King-Scott,
M.W.Parker,
and
A.F.Lopez
(2009).
The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.
|
| |
Blood,
114,
1289-1298.
|
 |
|
|
|
|
 |
X.Wang,
P.Lupardus,
S.L.Laporte,
and
K.C.Garcia
(2009).
Structural biology of shared cytokine receptors.
|
| |
Annu Rev Immunol,
27,
29-60.
|
 |
|
|
|
|
 |
X.Zhu,
W.D.Marcus,
W.Xu,
H.I.Lee,
K.Han,
J.O.Egan,
J.L.Yovandich,
P.R.Rhode,
and
H.C.Wong
(2009).
Novel human interleukin-15 agonists.
|
| |
J Immunol,
183,
3598-3607.
|
 |
|
|
|
|
 |
E.Mortier,
T.Woo,
R.Advincula,
S.Gozalo,
and
A.Ma
(2008).
IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.
|
| |
J Exp Med,
205,
1213-1225.
|
 |
|
|
|
|
 |
G.Hansen,
T.R.Hercus,
B.J.McClure,
F.C.Stomski,
M.Dottore,
J.Powell,
H.Ramshaw,
J.M.Woodcock,
Y.Xu,
M.Guthridge,
W.J.McKinstry,
A.F.Lopez,
and
M.W.Parker
(2008).
The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation.
|
| |
Cell,
134,
496-507.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.R.Malek
(2008).
The biology of interleukin-2.
|
| |
Annu Rev Immunol,
26,
453-479.
|
 |
|
|
|
|
 |
Y.Malka,
T.Hornakova,
Y.Royer,
L.Knoops,
J.C.Renauld,
S.N.Constantinescu,
and
Y.I.Henis
(2008).
Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain.
|
| |
J Biol Chem,
283,
33569-33577.
|
 |
|
|
|
|
 |
D.M.Soper,
D.J.Kasprowicz,
and
S.F.Ziegler
(2007).
IL-2Rbeta links IL-2R signaling with Foxp3 expression.
|
| |
Eur J Immunol,
37,
1817-1826.
|
 |
|
|
|
|
 |
M.A.Williams,
and
M.J.Bevan
(2007).
Effector and memory CTL differentiation.
|
| |
Annu Rev Immunol,
25,
171-192.
|
 |
|
|
|
|
 |
M.Chirifu,
C.Hayashi,
T.Nakamura,
S.Toma,
T.Shuto,
H.Kai,
Y.Yamagata,
S.J.Davis,
and
S.Ikemizu
(2007).
Crystal structure of the IL-15-IL-15Ralpha complex, a cytokine-receptor unit presented in trans.
|
| |
Nat Immunol,
8,
1001-1007.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.P.Kim,
J.Imbert,
and
W.J.Leonard
(2006).
Both integrated and differential regulation of components of the IL-2/IL-2 receptor system.
|
| |
Cytokine Growth Factor Rev,
17,
349-366.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
| |